The trials and tribulations of liver allocation

被引:10
作者
Lee, Eunice [1 ]
Johnston, Chris J. C. [2 ]
Oniscu, Gabriel C. [2 ,3 ]
机构
[1] Univ Melbourne, Austin Hosp, Dept Surg, Melbourne, Vic, Australia
[2] Edinburgh Transplant Ctr, Edinburgh, Midlothian, Scotland
[3] Univ Edinburgh, Edinburgh, Midlothian, Scotland
关键词
liver allocation; model for end-stage liver disease; outcomes; transplant benefit; UKELD; HEPATOCELLULAR-CARCINOMA; SURVIVAL BENEFIT; LIST MORTALITY; DISEASE MELD; CLIF-C; TRANSPLANTATION; MODEL; PRIORITIZATION; COMPLICATIONS; DONATION;
D O I
10.1111/tri.13710
中图分类号
R61 [外科手术学];
学科分类号
摘要
Allocation policies are necessary to ensure a fair distribution of a scarce resource. The goal of any liver transplant allocation policy is to achieve the best possible outcomes for the waiting list population, irrespective of the indication for transplant, whilst maximizing organ utilization. Organ allocation for liver transplantation has evolved from simple centre-based approaches driven by local issues, to complex, evidence-based algorithm prioritizing according to need. Despite the rapid evolution of allocation policies, there remain a number of challenges and new approaches are required to ensure transparency and equity on the decision-making process and the best possible outcomes for patients on the waiting list. New ways of modelling, together with novel outcome criteria, will be required to enable a dynamic adaptability of the allocation policies to the ever changing demographics of the donor population and the changing landscape of indications for transplantation.
引用
收藏
页码:1343 / 1352
页数:10
相关论文
共 71 条
  • [1] Complications of Living Donor Hepatic Lobectomy-A Comprehensive Report
    Abecassis, M. M.
    Fisher, R. A.
    Olthoff, K. M.
    Freise, C. E.
    Rodrigo, D. R.
    Samstein, B.
    Kam, I.
    Merion, R. M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1208 - 1217
  • [2] Striving for more just allocation of liver allografts between patients with and without hepatocellular carcinoma: successes and challenges
    Ahearn, Aaron
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2020, 25 (01) : 42 - 46
  • [3] [Anonymous], 2019, NHSBT POLICY POL196
  • [4] [Anonymous], 2019, NHSBT LIVER TRANSPLA
  • [5] [Anonymous], 1998, Computerized Support Enforcement Systems
  • [6] [Anonymous], 1984, US STATUT LARGE, V98, P2339
  • [7] Elective Liver Transplant List Mortality: Development of a United Kingdom End-Stage Liver Disease Score
    Barber, Kerri
    Madden, Susanna
    Allen, Joanne
    Collett, Dave
    Neuberger, James
    Gimson, Alexander
    [J]. TRANSPLANTATION, 2011, 92 (04) : 469 - 476
  • [8] CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with acute on chronic liver failure admitted to the ward
    Barosa, Rita
    Roque-Ramos, Lidia
    Patita, Marta
    Nunes, Goncalo
    Fonseca, Jorge
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (06) : 399 - 405
  • [9] Liver Transplant Recipient Survival Benefit with Living Donation in the Model for Endstage Liver Disease Allocation Era
    Berg, Carl L.
    Merion, Robert M.
    Shearon, Tempie H.
    Olthoff, Kim M.
    Brown, Robert S., Jr.
    Baker, Talia B.
    Everson, Gregory T.
    Hong, Johnny C.
    Terrault, Norah
    Hayashi, Paul H.
    Fisher, Robert A.
    Everhart, James E.
    [J]. HEPATOLOGY, 2011, 54 (04) : 1313 - 1321
  • [10] Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States
    Berry, Kristin
    Ioannou, George N.
    [J]. GASTROENTEROLOGY, 2015, 149 (03) : 669 - 680